Supplementary Materials and Methods
Human fecal sample collection Fecal samples were collected from 71 adult patients with relapsing-remitting multiple sclerosis that had not received treatment for at least 3 months prior to the time of collection and 71 controls without autoimmune disorders at the University of California, San Francisco (UCSF) and the Icahn School of Medicine at Mt Sinai (New York, NY). The inclusion criteria specified no use of antibiotics or cancer therapeutics in 3 months prior to the study. Detailed patient information is available in Supplementary Table 1 . Samples were collected using culture swabs (BD #220135) and stored at -80C until DNA extraction or bacterial isolation.
16S rRNA amplicon sequencing and computational analysis of human and mouse microbiome samples DNA was extracted from samples using MoBio Power Fecal DNA extraction kit (MoBio #12830) and amplicons of V4 region of the prokaryotic 16S rRNA gene were sequenced using the Earth Microbiome Project standard protocol (1) . Analysis was performed using QIIME v1.9 as described (2) . Essentially, amplicon sequences were quality-filtered and grouped to "specieslevel" OTUs using SortMeRNA method (3) using GreenGenes version 13.8 97% dataset for closed reference. Sequences that did not match reference sequences in the GreenGenes database were dropped from the analysis. Taxonomy was assigned to the retained OTUs based on the GreenGenes reference sequence, and the GreenGenes tree was used for all downstream phylogenetic community comparisons. Samples were filtered to at least 10000 sequences per sample, and OTUs were filtered to retain only OTUs present in at least 5% of samples and covering at least 100 total reads. After filtering samples were rarefied to 10000 sequences per sample. We identified 129 total genera and 1462 total operational taxonomic units (OTUs) in our samples. We systematically compared relative abundances of individual microbial taxa between MS patients and controls at the genus and OTU levels by negative binomial Wald test using Benjamini-Hochberg correction for multiple comparisons (4). Alpha diversity was calculated using the Chao1 method (5) . For analysis of beta diversity, pairwise distance matrices were generated using the phylogenetic metric unweighted UniFrac (6) and used for principal coordinate analysis (PCoA). For comparison of individual taxa, samples were not rarefied. Instead, OTU abundances were normalized using variance-stabilizing transformation and taxa distributions were compared using Wald negative binomial test from R software package DESeq2 as described previously (4, 7) with Benjamini-Hochberg correction for multiple comparisons. All statistical analyses of differences between individual bacterial species were performed using QIIME v.1.9 or R (packages DESeq2 and phyloseq).
Comparison of functional pathways expressed by microbiota
A matrix of containing samples and OTU counts was obtained for all datasets using QIIME (described above 
Bacterial extract preparation for stimulation of human PBMCs
We used a combined experimental approach based on previously published studies to prepare bacterial extracts (9) and combine them with human PBMCs (10), followed by standard Th1 and Treg differentiation protocols (11, 12) . All PBMC responses to bacterial extracts were compared to no-bacteria vehicle controls that contained the same protease and phosphatase inhibitors. PBMCs were immunostained and analyzed using standard flow cytometry protocols (described in detail in Supplementary Materials and Methods).
Total bacteria were isolated from patient or control stool samples by suspending ~0.5mg stool sample in 1.5ml PBS, passing it three times through a 40um cell strainer and washing twice with 1.5ml PBS by spinning at 8000rpm. Individual bacterial species were ordered directly from ATCC. Parabacteroides distasonis (ATCC #8503) was grown on pre-reduced OxyPRAS Brucella Blood Agar plates (Oxyrase #P-BRU-BA) or in MTGE broth (Anaerobe Systems #AS-778) for 2 days anaerobically. Akkermansia muciniphila (ATCC #BAA-835) was grown on Tryptic Soy Blood Agar plates (Anaerobe Systems, #AS-542) or in OxyPRAS BHI broth (Oxyrase #BHI-HK) for 3 days anaerobically. Acinetobacter calcoaceticus (ATCC #23055) was grown on OxyPRAS Brucella Blood Agar plates or in Brucella Broth (Anaerobe Systems #AS-105) for 2 days aerobically.
Human PBMC isolation and stimulation with bacterial extracts
Peripheral blood mononuclear cells were isolated from healthy controls or RRMS patients and stored at -80C in cryovials at 10^7 cells/ml concentration in FBS containing 10% DMSO. Before plating, cells were washed in PBS twice, re-counted, and plated at 10^6 cells/ml concentration in RPMI media supplemented with 10% FBS and 1% penicillin/streptomycin/glutamine.
After isolation bacteria were resuspended in PBS supplemented with protease inhibitor (Roche #4693159001) and phosphatase inhibitor (Roche #4906845001), heat-inactivated at 65C for 1h and sonicated for 10min as described previously (9) . Protein concentration in the resulting suspension was measured using the Pierce BCA protein assay kit (Thermo Scientific #23227).
Bacterial extracts were added to PBMCs at 0.1µg/ml (A. calcoaceticus) or at 1µg/ml (A. muciniphila, P. distasonis), to represent their relative abundances, 1h after plating as described previously (10) . Each experiment contained at least 6 independent donor samples and was repeated at least twice with no more than 50% overlap between donors. .
For human Treg differentiation, cells were stimulated with anti-human CD3 (BD #555336, 0.3 µg/ml), anti-human CD28 (BD #555725, 2 µg/ml) and recombinant human TGF-β1 (R&D #240B002, 2.5ng/ml) for 4 days (12), in presence of bacterial extracts. For human Th1 differentiation, cells were stimulated with anti-human CD3 (BD #555336, 2 µg/ml), anti-human CD28 (BD #555725, 2 µg/ml), anti-human IL-4 (BioLegend #500702, 5 µg/ml) and recombinant human IL-12 (Thermo Fisher Scientific #NBP143214, 20ng/ml) for 3 days (11), in presence of bacterial extracts. After 3 days the culture media was changed and Th1 cells were restimulated for 4 hours with 1µM ionomycin and 50ng/ml PMA in presence of 2 µM monensin, in absence of bacterial extracts.
Flow cytometry of human PBMCs
Live/dead cell gating was achieved using Live/Dead Fixable Aqua kit (ThermoFisher #L34957). BD Cytofix/Cytoperm kit (BD #554722) was used for staining of intracellular cytokines, and FoxP3/Transcription factor staining buffer set (eBioscience #00-5523-00) for transcription factors. The following antibodies were used for human PBMC staining: anti-CD3-PE.Cy7 (BD #563423), anti-CD4-PerCP.Cy5.5 (BioLegend #300530 or BD #560650) and anti-CD25-PE (BD #555432) or anti-CD25-BV421 (BD #562442) or anti-CD25-APC (BD #555434), anti-IFNγ-FITC (BioLegend #502506), anti-Tbet-PE (BD #561265), anti-FoxP3-AlexaFluor-488 (BD #560047) and anti-IL-10-PE (eBioscience #12-7108). Flow cytometry was performed on BD Fortessa cell analyzer and analyzed using FlowJo software (TreeStar). For both mouse and human PBMC flow cytometry, cells were gated to identify the lymphocyte population based on forward and side scatter, followed by gating for single cell and live cell populations. Unstained, single color and fluorescence-minus-one controls were used to identify stained populations.
Verification of germ-free or antibiotic-treated mouse status
Colonization level of GF mice was verified by quantification of colony forming units of bacteria in mouse feces, cultured anaerobically (Suppl. Fig. S11A ) and colonization specificity was verified by PCR (Suppl. Fig. S11B ). In bacterial monocolonization experiments, mice were euthanized and immunophenotyping was performed 3-4 weeks after colonization. GF mice remained in isolators for the duration of the experiment and transferred out when euthanized. GF mice that were subsequently associated with fecal microbes or single species of bacteria were taken out of isolators at 3-4 weeks of age and colonized with a single oral gavage. In experiments without EAE induction, GF control groups were kept in isolators until mice were euthanized for immunophenotyping. In experiments with EAE induction, GF mice were removed from the isolators in order to induce EAE, and maintained GF outside of the isolators by supplementing drinking water with erythromycin and gentamycin until the end of the experiment. In order to ensure that the GF animals remained GF both inside and outside the isolators, their stool samples were repeatedly plated on Brucella blood agar plates and cultured both aerobically and anaerobically. GF mice were determined to be clean after no colonies could be observed on the plates after a week of incubation.
To ensure that broad-spectrum antibiotic treatment depletes stool bacteria, total bacteria isolated from mouse stool was cultured on Brucella Blood Agar plates and no colonies were observed. Antibiotic-mediated depletion of microbiota was further verified by comparing community richness in antibiotic-treated mice and SPF controls (Suppl. Fig. S12 ; Chao1 metric of alpha diversity).
Mouse colonization with microbiota
Germ-free (GF) mice were bred and maintained in sterile isolators that were assayed every two weeks for GF status by bacterial plating and PCR. Fecal material from human donor samples or individual bacteria species at 10^8 CFU/mouse was diluted to a final solution of 1.5% sodium bicarbonate. For colonization experiments following antibiotic treatment, mice were treated with 1% solution of Amphotericin B in drinking water for 3 days, followed by 2 weeks of antibiotic solution composed of 1% Amphotericin B, 1mg/ml ampicillin, 1mg/ml neomycin, 1mg/ml metronidazole and 0.5mg/ml vancomycin in drinking water; 1% Amphotericin B solution was used as a control. After 2 weeks, we replaced the drinking solution by sterile water and mice were gavaged by specific bacteria of interest in a solution of 1.5% sodium bicarbonate at 10^8 CFU/mouse every 2-3 days for 2 weeks. SPF mice were gavaged with mock culture medium every 2-3 days for 2 weeks to mimic the esophageal trauma.
Induction of EAE
EAE was induced 6-7 weeks after colonization, corresponding to 9-10 weeks of age. Mice were subcutaneously immunized in the upper and lower back with 0.1ml MOG 35-55 emulsion (1mg/ml) mixed with Complete Freud's Adjuvant and killed mycobacterium tuberculosis H37Ra (2-5mg/ml), followed by two 0.1ml intraperitoneal injections of pertussis toxin (4µg/ml) approximately 2 and 26 hours later (Hooke Laboratories #EK-2110). Mice were scored daily in a blinded fashion for motor deficits as follows: 0, no deficit; 1, limp tail only; 2, limp tail and hind limb weakness; 3, complete hind limb paralysis; 4, complete hind limb paralysis and partial/complete forelimb paralysis; 5, moribund.
Mouse immune cell isolation and intracellular cytokine staining
Mesenteric lymph nodes, cervical lymph nodes, and spleens were dissected and processed by grinding tissues through a 100um cell strainer. Single cell suspensions were incubated for 4-5 hours with 50ng/ml PMA, 2µg/ml ionomycin in presence of 2µg/ml protein transport inhibitor (GolgiPlug, BD #51-2301KZ). Cells were then incubated in 5% mouse serum for 15 min and stained for 20 min at 4ºC with Live/Dead Fixable Violet kit (Life Technologies #L34964) or Live/Dead Fixable Aqua kit (ThermoFisher #L34957) and anti-CD4-PE-Cy7 (eBioscience #25-0042-82). Cells were fixed and permeabilized with FoxP3/Transcription factor buffer set (eBioscience #00-5523-00), and stained with anti-Foxp3-APC (eBioscience, #17-5773-82) and anti-IL10-PE (eBioscience #12-7101-82), anti-IFNγ-FITC (eBioscience, #11-7311-82), anti-IL17-PerCP/Cy5.5 (eBioscience #45-7177-82).
RNAseq analysis in gnotobiotic mouse spinal cords RNA was isolated from whole spinal cord of transplanted mice, checked for RNA integrity and sequenced at the New York Genome Center. Samples were pair-end sequenced and each sample generated 100 million reads (50 million read-pairs). Raw reads were then aligned to the Ensemble reference genome (mapping rate = 80%). Differential expression of transcripts was analyzed using the DESeq2 package. We identified transcripts with baseMean (average count value normalized to library size) > 5 and a log2 fold change of at least 1.5. Since we were interested in determining changes in the spinal cord that occurred in GF mice transplanted with MS or control microbiota in response to EAE, we focused on transcripts with differential expression between pre-induction and at 35 days post-induction. A greater number of differentially expressed transcripts was identified in the spinal cord of GF mice transplanted with MS stools compared to controls. To begin understanding the cell type that could drive this transcriptional difference, we used this dataset to interrogate a cell-enrichment gene list that we generated using the data from Zhang et al. (J Neurosci. 2014 Sep 3;34(36):11929-47) and considering "cell-specific" those genes whose expression was at least 10 folds higher in one cell type than in any other. Six cell-specific lists were generated for astrocytes, myelinating oligodendrocytes, neurons, oligodendrocyte precursor cells, microglia and endothelial cells.
Statistical analysis of in vitro data
Statistical significance of expression changes in markers of T lymphocyte differentiation and proliferation was determined using two-tailed Student's t test to compare samples from different donors, two-tailed repeated measures t test to compare samples from the same donor, and one or two-way ANOVA to compare samples from different donors in different groups based on bacterial presence. When data was non-normally distributed, two-tailed nonparametric MannWhitney test was used instead. Benjamini-Hochberg adjustment was used to account for multiple comparisons. GraphPad Prism 6 software was used to analyze and plot the data. P < 0.05 was considered statistically significant.
Supplementary Discussion
While no major shifts in microbial diversity were identified, specific bacterial taxa were found to be significantly under-or over-represented in untreated MS patients compared to healthy controls. In vitro studies of MS-associated bacterial species revealed that even modest dysbiosis could drive a two-stage, immune deviation mechanism (either sequential or parallel), ultimately resulting in skewed T lymphocyte differentiation. Acinetobacter and Akkermansia species induces a pro-inflammatory environment, mediated by reduction in CD25+FoxP3+ Tregs and expansion of Th1 lymphocytes. On the other hand, a potential concomitant decrease in P. distasonis mediates a relative loss of CD25+IL-10+ T lymphocytes. Furthermore, we show that MS-associated microbiota inhibits IL-10+ T lymphocyte responses in vivo and increases disease severity in a mouse model of MS.
The interaction between microbiota and the immune system is likely bidirectional, as suggested by impaired lymphocyte responses of MS patients to self microbiota, but no difference in control lymphocyte responses to either control or MS non-self microbiota (SI Appendix, Fig. S10 ). The observed reduction in Parabacteroides, increase in Acinetobacter and increase in Akkermansia may together or separately contribute to inflammation and disease severity without being the only factors that account for the development of the disease. Thus, it is essential to view our findings not as an exclusive list of immunoregulatory microbiota, but rather as the first step in investigating the microbial species and pathways that contribute to the regulation of autoimmune inflammation in MS and other diseases.
In contrast to recent publications profiling the microbiome in MS and other chronic diseases (13-16), we focused exclusively on patients not receiving disease-modifying therapeutics at the time of sample collection to decouple the effects of the disease and therapy, a valuable strategy highlighted in a recent report on Crohn's disease (17) . In concordance with prior studies in MS, we did not observe global changes in microbial community structures. However, the larger sample size in our study allowed us to identify individual bacterial taxa that are potentially associated with autoimmunity. In addition, in contrast to studies on MS microbiota that were limited to identifying correlations between microbial taxa and host phenotypes (18), we were able to investigate microbial immunoregulatory effects in vitro and in vivo.
Our taxa-specific investigation was focused on commensal microbiota, not infectious pathogens. Akkermansia and Parabacteroides are commensal and even Acinetobacter, even though it is typically acquired as an infection, is not considered a pathogen once it inhabits the human gut. We consciously chose to investigate the physiological contribution of commensals to systemic inflammation, as their ability to alter T lymphocyte differentiation is likely to create a systemic environment that may exacerbate inflammation in the host without overt infection, which constitutes a plausible model for MS etiology.
Our results suggest that both rare and common microbiota may play a role in the exacerbation of autoimmune inflammation in MS. Notably, the presence of the relatively common bacterial species A. muciniphila in total stool bacteria was sufficient to recapitulate its functions of skewing PBMC responses towards pro-inflammatory Th1 phenotype. Apart from their A. muciniphila content, the microbiomes of the subjects analyzed here were highly heterogeneous based on 16S sequencing, which further supports the hypothesis that A. muciniphila is one of the keystone species sufficient to drive the microbiota towards Th1 induction. Despite this intriguing result, A. muciniphila is unlikely to be the only microbial species that is sufficient to induce Th1 differentiation. Instead, the discovery of A. muciniphila as a major pro-inflammatory regulator may be considered as the first step in identifying other microbes and microbial pathways that are sufficient for inducing Th1 differentiation.
Of note, the pro-inflammatory role of A. muciniphila observed in our in vitro experiments was not replicated in monocolonized mice. This difference may be caused by differences in mouse and human immune cell responses to A. muciniphila. In addition, the main in vivo role of A. muciniphila may have little to do with its direct effects on T cells: it may instead shape the rest of the microbial community towards more pro-inflammatory phenotype. This function would explain why A. muciniphila is more abundant in untreated MS patients both in our study and a previous investigation of an independent cohort (19) , and is sufficient to induce proinflammatory functions of total microbial community.
Despite rarely detected in the human gut, Acinetobacter had a higher relative abundance in MS patients. Although it cannot be considered as a universal contributor to MS severity due to its rarity, we view it as one of multiple environmental contributors that are able to exacerbate the disease. Its role may be explained by drawing an analogy to genetics: same as a specific allele, a specific bacterial species may be rare overall, but significantly increased in MS patients compared to controls, and contribute to disease severity in those few MS patients in which it is present.
Furthermore, we observed a consistent association between healthy control microbiota and CD25+IL-10+ lymphocyte differentiation both in vitro and in vivo. A similar result is presented in the accompanying article where blocking IL-10 results in increased EAE incidence (Berer et al. ) . It has been previously reported that IL-10 deficient mice are susceptible to colitis induced by transplantation of normal mouse microbiota or simplified human microbiota (20, 21). Thus, CD25+IL-10+ lymphocyte differentiation in response to healthy microbiota, and especially to a common and highly abundant bacterial species like P. distasonis, may serve as a built-in control mechanism to dampen the pro-inflammatory characteristics of other microbial species. The loss of this mechanism due to MS-associated dysbiosis may then create a pro-inflammatory environment, which may further exacerbate the disease. Tables   Supplementary,Table, 
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